πŸ‡ΊπŸ‡Έ FDA
Patent

US 7674777

Immunostimulatory nucleic acid molecules

granted A61KA61K2039/55561A61K31/00

Quick answer

US patent 7674777 (Immunostimulatory nucleic acid molecules) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/55561, A61K31/00, A61K31/4706, A61K31/7048